254 related articles for article (PubMed ID: 28870775)
1. Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease.
Nickel RS; Kamani NR
Biol Blood Marrow Transplant; 2018 Feb; 24(2):219-227. PubMed ID: 28870775
[TBL] [Abstract][Full Text] [Related]
2. Barriers to conceiving sibling donors for sickle cell disease: perspectives from patients and parents.
Jae GA; Lewkowitz AK; Yang JC; Shen L; Rahman A; Del Toro G
Ethn Health; 2011; 16(4-5):431-45. PubMed ID: 21797728
[TBL] [Abstract][Full Text] [Related]
3. Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.
Walters MC; De Castro LM; Sullivan KM; Krishnamurti L; Kamani N; Bredeson C; Neuberg D; Hassell KL; Farnia S; Campbell A; Petersdorf E
Biol Blood Marrow Transplant; 2016 Feb; 22(2):207-211. PubMed ID: 26500093
[TBL] [Abstract][Full Text] [Related]
4. Should young children with sickle cell disease and an available human leukocyte antigen identical sibling donor be offered hematopoietic cell transplantation?
Krishnamurti L
Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):53-57. PubMed ID: 32202246
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
Aslam HM; Yousuf S; Kassim A; Iqbal SM; Hashmi SK
Bone Marrow Transplant; 2018 Nov; 53(11):1390-1400. PubMed ID: 29728697
[TBL] [Abstract][Full Text] [Related]
6. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
[TBL] [Abstract][Full Text] [Related]
7. Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.
Guilcher GMT; Truong TH; Saraf SL; Joseph JJ; Rondelli D; Hsieh MM
Semin Hematol; 2018 Apr; 55(2):87-93. PubMed ID: 29958564
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation in sickle cell anemia.
Hoppe CC; Walters MC
Curr Opin Oncol; 2001 Mar; 13(2):85-90. PubMed ID: 11224704
[TBL] [Abstract][Full Text] [Related]
9. Haematopoietic cell transplantation in the treatment of sickle cell disease.
Atkins RC; Walters MC
Expert Opin Biol Ther; 2003 Dec; 3(8):1215-24. PubMed ID: 14640947
[TBL] [Abstract][Full Text] [Related]
10. The ethics of a proposed study of hematopoietic stem cell transplant for children with "less severe" sickle cell disease.
Nickel RS; Hendrickson JE; Haight AE
Blood; 2014 Aug; 124(6):861-6. PubMed ID: 24963044
[TBL] [Abstract][Full Text] [Related]
11. Update of hematopoietic cell transplantation for sickle cell disease.
Walters MC
Curr Opin Hematol; 2015 May; 22(3):227-33. PubMed ID: 25767957
[TBL] [Abstract][Full Text] [Related]
12. Has stem cell transplantation come of age in the treatment of sickle cell disease?
Shenoy S
Bone Marrow Transplant; 2007 Nov; 40(9):813-21. PubMed ID: 17704797
[TBL] [Abstract][Full Text] [Related]
13. When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease.
Joseph JJ; Abraham AA; Fitzhugh CD
Semin Hematol; 2018 Apr; 55(2):94-101. PubMed ID: 29958565
[TBL] [Abstract][Full Text] [Related]
14. Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
Bitan M; van Walraven SM; Worel N; Ball LM; Styczynski J; Torrabadella M; Witt V; Shaw BE; Seber A; Yabe H; Greinix HT; Peters C; Gluckman E; Rocha V; Halter J; Pulsipher MA
Biol Blood Marrow Transplant; 2016 Jan; 22(1):96-103. PubMed ID: 26307344
[TBL] [Abstract][Full Text] [Related]
15. How I treat sickle cell disease with hematopoietic cell transplantation.
Stenger EO; Shenoy S; Krishnamurti L
Blood; 2019 Dec; 134(25):2249-2260. PubMed ID: 31697818
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic donor availability for hematopoietic stem cell transplantation in children with sickle cell disease.
Justus D; Perez-Albuerne E; Dioguardi J; Jacobsohn D; Abraham A
Pediatr Blood Cancer; 2015 Jul; 62(7):1285-7. PubMed ID: 25663074
[TBL] [Abstract][Full Text] [Related]
17. New approaches to hematopoietic cell transplantation for hematological diseases in children.
Woodard P; Lubin B; Walters CM
Pediatr Clin North Am; 2002 Oct; 49(5):989-1007. PubMed ID: 12430622
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell transplantation for sickle cell disease: updates and future directions.
Krishnamurti L
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):181-189. PubMed ID: 34889368
[TBL] [Abstract][Full Text] [Related]
19. Bone Marrow-Derived Mesenchymal Stromal Cells from Patients with Sickle Cell Disease Display Intact Functionality.
Stenger EO; Chinnadurai R; Yuan S; Garcia M; Arafat D; Gibson G; Krishnamurti L; Galipeau J
Biol Blood Marrow Transplant; 2017 May; 23(5):736-745. PubMed ID: 28132869
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation in sickle cell disease.
Vermylen C
Blood Rev; 2003 Sep; 17(3):163-6. PubMed ID: 12818226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
